Skip to main content
. 2023 May 1;6:78. doi: 10.1038/s41746-023-00806-x

Table 4.

Comparison of performance in the external testing set (n = 13,988).

Event and time point AUC Full model (1) AUC Perfusion abnormality (2) AUC Clinical-only model (3) p value (1) versus (2) p value (1) versus (3) p value (2) versus (3)
MACE at 1 year 0.74 (0.73, 0.76) 0.71 (0.70, 0.73) 0.68 (0.66, 0.69) <0.001 <0.001 0.001
MACE at 3 years 0.73 (0.72, 0.74) 0.69 (0.67, 0.70) 0.69 (0.68, 0.71) <0.001 <0.001 0.341
Death at 1 year 0.77 (0.74, 0.80) 0.61 (0.58, 0.65) 0.75 (0.72, 0.78) <0.001 0.320 <0.001
Death at 3 years 0.76 (0.73, 0.78) 0.61 (0.58, 0.64) 0.72 (0.70, 0.74) <0.001 0.026 <0.001
ACS at 1 year 0.74 (0.70, 0.78) 0.69 (0.64, 0.74) 0.72 (0.68, 0.76) 0.021 0.426 0.343
ACS at 3 years 0.72 (0.69, 0.74) 0.65 (0.62, 0.68) 0.70 (0.68, 0.73) <0.001 0.469 0.012
Revasc. at 1 year 0.74 (0.73, 0.76) 0.74 (0.72, 0.76) 0.66 (0.64, 0.68) 0.763 <0.001 <0.001
Revasc. at 3 years 0.72 (0.70, 0.74) 0.72 (0.70, 0.74) 0.67 (0.65, 0.69) 0.737 <0.001 <0.001

All p values were obtained using DeLong’s test. The bold values represent statistically significant (p < 0.05) comparisons. Abbreviations: ACS acute coronary syndrome, AUC area under the receiver-operating curve, MACE major adverse cardiovascular event, Revasc. revascularization.